In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Treating Secondary Mitral Regurgitation: Changing the Course of Heart Failure

Industry Discoveries organised by Abbott

logo-abbott
Title
Speaker
Slides
Video
Q&A
  • Title: Introduction.
    Speaker: J Lindenfeld (Nashville,US)

    NA

    Video:
  • Title: Secondary Mitral Regurgitation in Heart Failure: How does it impact your patients?
    Speaker: F Gustafsson (Copenhagen,DK)

    NA

    Video:
  • Title: Challenges in managing Heart Failure Patients and Implication of The COAPT Trial: Clinical Outcomes in Heart Failure Patients with clinically significant Mitral Regurgitation.
    Speaker: J Lindenfeld (Nashville,US)

    NA

    Video:
  • Title: How do I interpret the COAPT evidence and what does this mean for my practice?
    Speaker: JN Trochu (Nantes,FR)

    NA

    Video:
  • Title: Conclusion and Take-Home messages.
    Speaker: J Bax (Leiden,NL)

    NA

    Video:
  • Title: How should Heart Failure patients with clinically significant Mitral Regurgitation be managed.
    Speaker: J Bax (Leiden,NL), F Gustafsson (Copenhagen,DK), J Lindenfeld (Nashville,US), JN Trochu (Nantes,FR), R Von Bardeleben (Mainz,DE), M Borger (Leipzig,DE)

    NA

    Video:
  • Title: Treating Secondary Mitral Regurgitation: Changing the Course of Heart Failure.
    Speaker:

    NA

    Video:

The content of these presentations reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.

 

  Back to the Industry Discoveries